Abstract: Disclosed are multibinding compounds which inhibit cyclooxygenase-2 (COX-2), an enzyme which catalyzes the first committed step in the biosynthesis of prostaglandins. The multibinding compounds of this invention containing from 2 to 10 ligands covalently attached to one or more linkers. Each ligand is a moiety capable of binding to COX-2. The multibinding compounds of this invention are useful in the treatment inflammation, pain, fever and the like.
Type:
Grant
Filed:
June 7, 1999
Date of Patent:
May 28, 2002
Assignee:
Advanced Medicine, Inc.
Inventors:
J. Kevin Judice, Deborah L. Higgins, John H. Griffin